Sulfonamides and trimethoprim.
Kalkut
G
G
Division of Infectious Diseases, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, New York, USA.
D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D000963:Antimetabolites / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D004338:Drug Combinations; D006801:Humans; D013449:Sulfonamides / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D014295:Trimethoprim / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D015662:Trimethoprim, Sulfamethoxazole Drug Combination / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use
D000900:Anti-Bacterial Agents; D000963:Antimetabolites; D004338:Drug Combinations; D013449:Sulfonamides; D015662:Trimethoprim, Sulfamethoxazole Drug Combination; D014295:Trimethoprim